A clinical perspective of Chemsex

Slides:



Advertisements
Similar presentations
10 year history serving the Substance Use needs of Londons LGBT ( L esbian, G ay, B isexual & T ransgender) community 8,000 contacts, 700+ people in various.
Advertisements

What is good HIV prevention? Ross Boseley Health promotion Coordinator Terrence Higgins Trust Brighton.
Providing substance misuse support to LGB & T people New trends, challenges and developing a strategic approach through commissioning Monty Moncrieff.
CLINICS AND COMMUNITY Dr Mags Portman.
Robin Pollard Operations Coordinator Youth RISE.
CLUB DRUGS Dr Alexander Margetts, Clinical Psychologist
LGBT* Dual Diagnosis Pat, Mark, Andy. Stonewall- Gay and Bisexual Men’s Health Survey ,861 gay and bisexual male respondents from across Britain.
2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.
The UK’s only LGBT Substance Misuse Service 10 year history serving the Substance Use needs of London’s LGBTQ community 8,000 contacts, 700+ people in.
Substance misuse sector Or Sexual health sector? Is this a drug problem Or A sex problem?
Chemsex: a treatment response Monty Moncrieff Chief Executive, London Friend HIV Prevention England Conference 19 th February 2015.
Introduction PRO(TECT) is a partnership project between Terrence Higgins Trust and The Claude Nicol Clinic (CNC) GUM in Brighton. It provides a new tailor-made.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
POSITIVE PREVENTION Key to stemming HIV transmission Ms. Lovette Byfield Prevention Coordinator National HIV/STI Control Program.
Brief Interventions for HIV+ Persons Thomas L. Patterson Shirley J. Semple University of California, San Diego Research supported by NIMH RO1MH61146 &
Aimed at Key Affected Population Groups.  Clinical social franchising is a model for organizing networks of private providers  to deliver a range of.
Substance Use, Substance Choice, and Unprotected Sex among Young Asian/Pacific Islander (API) Men Who Have Sex with Men (MSM) Kyung-Hee Choi, 1 Don Operario,
Persistent Offender Project Persistent Offender Project Joint Partnership between Glasgow Addiction Service & Strathclyde Police Funded by Glasgow Community.
Bheki Sithole 30 Nov Sibayeni Lodge Most at Risk Behavior Populations (MSM): Feedback, Challenges and Experiences.
HIV in the United Kingdom: 2013 Report Public Health England » At end 2012, men who have sex with men (MSM) remain the group with highest prevalence of.
Dr. Grady L. Garner Jr. DePaul University Young Black MSM and HIV: Awareness, Behavior, and Societal Contributions.
Cocaine Services IN AN IDEAL WORLD – HOW SHOULD THEY WORK?
Needs Assessment: Young People’s Drug and Alcohol Services in Edinburgh City EADP Children, Young People and Families Network Event 7 th March 2012 Joanne.
California HIV Prevention Indicators 2 nd Edition McCandless RR 1,Truax SR 2, Aoki BK 1, Lemp GF 1, Montgomery M 2, Webb DS 2, Lees N 2 1 Universitywide.
All Change! Infections, injecting drug use and harm reduction. Vivian Hope IDU Team, HIV & STI Department, Health Protection Services – Colindale Dr Vivian.
Injection drug use among men who have sex with men (MSM) Dr Adam Bourne Sigma Research London School of Hygiene & Tropical Medicine
Reaching out to drug users and communities “ ” WDP Preventing HIV Yasmin Batliwala.
HIV and African M S M in England: A new wave of Challenge. Presented by Adebisi Alimi.
S. Sutherland, L. Byfield, N. Cooper National HIV/STI Programme, Ministry of Health Jamaica, West Indies.
getting the message across
Darrin Aiken – Program Coordinator Christopher Jackson – Prevention Training Specialist.
HIV/AIDS, Housing and Risk Behaviors CT AIDS Resource Coalition and CIRA Community Research Partnership Program.
Young Person’s substance misuse service in Hampshire Julie Poling – Team Leader.
PREVENTION OF DRUG ABUSE AMONG VULNERABLE GROUPS Dr Marcus Roberts Director of Policy and Membership DRUGSCOPE.
Conversation 4: Community Perspectives on Chemsex
The recovery agenda – a pharmacy perspective
Substance Misuse in LGBT populations
Is on-demand PrEP a suitable tool for MSM who practice chemsex
IAS Satellite Session 25th July 2017 Daniel Were, PhD
Sex between men that occurs under the influence of Mephedrone, GHB/GBL or Crystal Meth
56 Dean Street, Chelsea and Westminster Hospital, London
Young people, substance misuse and PHE
Drugs.
**Funded in part by NIMH RO3MH and NCRR K12RR017707
Project START Intervention Increases HIV Testing Uptake and Decreases HIV Risk Behavior among Men Released from Prison: a Randomized Controlled Study.
The Albert Kennedy Trust – No young person should have to
LGBTQ+ Mental Health and Suicide
BSL Healthy Minds Supporting Deaf people's mental health through their own language and culture 1 December 2017.
The development of a training programme for C-BIT
WORLD AIDS DAY 2018 HIV in the UK
Sexual Health and Wellbeing for Wales
NPS current health-related practices and challenges in responding to use and harms in Europe Findings from a multi-method study Alessandro Pirona Lisbon.
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Overview of importance and emerging innovations for testing and linkage CHERYL JOHNSON WORLD HEALTH ORGANIZATION HIV AND HEPATITIS DEPARTMENT 23 JULY.
Supporting and improving the wellbeing of LGBT+ communities
The role and state of the sector
Behavioral Activation Integrated with Sexual Risk Reduction Counseling for High-Risk MSM with Crystal Methamphetamine.
And Gender Based Violence
Drug use among MSM (overview with focus on chemsex)
STIs among people who use drugs
Secondary Prevention.
A Collaborative Response Kiran Santlal & Adam Shanley
WORLD AIDS DAY 2018 HIV in the UK
Recognise & Respond: Strengthening advocacy for LGBT+ survivors of domestic abuse Jasna Magić /
Lesson 3: Treatment as Prevention
Illustrative Cluster Detection and Response Strategy
2025 AIDS targets Technical meeting on prevention
Prevention of HIV infection: How effectively are countries responding to changing epidemics in the Asia Pacific Region? 30 March 2011 Slide 1 A brief introduction.
Sexually transmitted infections – trends and challenges
#endHIVbg: an Innovative National Campaign to Engage Hard-to-reach
Presentation transcript:

A clinical perspective of Chemsex Dr Jake Bayley Consultant Sexual Health and HIV Barts Health NHS Trust Slides courtesy of Dr Adam Bourne, LSHTM

Use of drug in last year, British Crime Survey 2007/8 All respondents Men Straight % (n/N)   Gay/Bisexual % (n/N) Adjusted Odds Ratio* (95%CI) Cannabis 7.1 (1593/22309) 9.4 (946/10011) 18.8 (46/245) 1.73 1.22-2.43 Cocaine 2.2 (495/22374) 3.1 (311/10045) 7.4 (18/244) 1.92 1.15-3.18 Amyl nitrite 1.4 (307/22421) (142/10069) 24.4 (60/246) 23.04 16.00-33.18 Ecstasy 1.3 (299/22393) 1.8 (182/10053) 6.5 (16/245) 2.88 1.67-4.96 Amphetamine 1.1 (244/22352) (132/10039) 3.7 (9/246) 2.28 1.14-4.58 Tranquilisers 0.5 (111/22438) 0.4 (45/10076) 2.8 (7/247) 4.33 1.90-9.87 Magic mushrooms (81/22420) (50/10065) 5.14 2.27-11.66 Ketamine 0.3 (65/22437) (31/10079) 10.01 4.60-21.77 LSD 0.2 (52/22414) (31/10063) 1.6 (4/247) 4.03 1.39-11.69 Crack 0.1 (28/22428) (19/10072) 0.8 (2/247) 2.68 0.61-11.84 Heroin (26/22438) (17/10077) 2.90 0.65-12.91 Annual prevalence of drug use by sexuality in British Crime Survey 2007/8 Unpublished data from the British Crime Survey 2007/8. Data personal communication from Jacqueline Hoare (Home Office Statistics Unit); analysis by Ford Hickson (Sigma Research)

Current trends in drug use Name of drug Street names Delivery Mephedrone Meow Meow, MCAT, plant food Snorted as a powder, injected or administered rectally GHB/GBL G, Gina, liquid ecstasy Swallowed in small liquid doses Crystal meth Crystal, Ice, Tina, T Snorted as powder, smoked in glass pipe, or administered rectally Ketamine K, special K, Green Swallowed as tablet, snorted What we believe we may have seen over the past few years is a migration away from those drugs previously popular to newer psychoactive substances. We don’t yet have published national level data to reinforce this for gay men, but health practionner discourse – what they’re seeing in clinic and in services – overwhelmingly supports this switch, especially the case with mephedrone. I’ve added Ketamine to this list because while it’s not a key factor on the UK chemsex scene, I’m aware it is in other countries. Chemsex: “Sex between men that occurs under the influence of [these] drugs taken immediately preceding and/or during the sexual session”

Chemsex 'prevalence' (UK) European MSM Internet Survey (EMIS) 15,423 MSM living in England 0.7% had used crystal meth in previous 4 weeks (London 2.9%) 2.9% had used mephedrone in previous 4 weeks (London 10.2%) 1.6% had used GHB/GBL in previous 4 weeks (London 5.5%) Chemsex drug use highest among HIV positive gay men 8.6% of HIV positive men used crystal meth Vs <1% negative or untested men 13.5% of HIV positive men used GHB/GBL Vs <3% of negative or untested men (i.e. 8 crystal use 8 times higher)

Chemsex & sexual health Maintenance of safer sex behaviour Pre-determined unprotected anal intercourse Unintended sexual risk under the influence of drugs Drug use associated with increased odds of UAI during group sex Three-fold increase in odds of UAI associated with use of crystal meth A proportion of men in both studies had decided to (nearly) always have sex without condoms Generally such men had diagnosed HIV All had condomless sex with men they believed to also be positive – Serosorting STIs often seen as inevitable part of lifestyle High rates of Hepatitis C (and re-infection) but limited awareness of protective behaviours A third of men had engaged in unintentional sexual risk behaviour Drugs had myopic effect Drugs could be cognitively incapacitating

Chemsex & broader well-being Impact on mental health Anxiety attacks Acute paranoia Sexual dependency Impact on physical health Overdose Disturbed sleeping problems Injection site injuries Sexual consent concerns Bourne et al, 2015a; 2015b; Fourer et al, 2014; Knoops et al, 2015)

Conclusions – What we know The drugs most popular among MSM appears to have shifted Injection drug use has emerged as a source of concern for MSM Use of drugs in general is higher among MSM with diagnosed HIV Newly popular drugs lend themselves to use in sexual settings Chemsex is associated with a higher risk of HIV/STI transmission behaviour MSM using drugs are exposed to (and experience) a range of physical and mental health harms

“CHEMSEX” Tadgh Crozier & Louis Driver Senior Engagement Workers

WHO ARE WE? Lifeline Project – Registered charity providing national Drug & Alcohol Treatment. AFTER PARTY SERVICE – Started 2014 London based outreach service Supported and funded by the Elton John Aids Foundation One-to-one support, Harm reduction, Group work and Training. Focus on sexual health, HIV Prevention and provision Self Test HIV Kits.

What is CHEMSEX ? Having sex whilst using drugs Gay, bisexual, MSM Specific intention to meet, use and have sex Three main drugs: mephedrone, GHB/GBL, crystal methamphetamine

Why is it a concern? Marked change in drugs used Changing context and methods of use Increasing presentations to services – Sexual health and counselling Backdrop of rising HIV diagnoses & infections Clients not identifying as ‘that type’ of drug user (STIGMA) A move from the more traditional normalised use of recreational drugs onto harder Nps’S.

How have things have changed? Different drugs being used with different routes of administration Different harms – injecting, dependence (G), mental health (psychosis) Interventions need to include substance use, sexual behaviour & HIV prevention Interventions delivered in different settings - GUM clinics (motivational, preventative)

The drugs: Mephedrone  MIAOW, MEPH, MEOW MEOW, M-CAT, DRONE 

The drugs: GHB/GBL G, GINA, GEEBS, GBL, GBH, 

The drugs: Crystal Meth METHAMPHETAMINE, TINA, CHRISTINE, METH, ICE, GLASS, CRANK, 

‘Apps’ & ‘On-line’

What we’re seeing Sexualised drug using, multiple partners Meeting & trading of drugs through apps Private sex parties, sex on premises venues High level of current sexual risk ‘Slamming’ - Injecting (Crystal meth & Mephedrone) We have seen an increase in HIV infection as a result of Chemsex Poor adherence to HIV meds whilst using Lack of knowledge and understanding in relation to BBV’s Widespread poor self-esteem issues

What we’re hearing Concerns around consent whilst using – exploitation, rent, rape – Unconscious Slamming (injecting) on the increase as criterion for sex party admission Dealers offering needles to slamming users Filming and webcams at parties

Interventions Same principles: brief interventions, MI, CBT, SFT & relapse prevention But with cultural adaptations: e.g. relapse prevention through management of online sexual-social profiles Tackle sexual health and drug use together Delivered in LGBT-specific, or LGBT-competent locations Anecdotally 90% say ‘important’ or ‘very important’ to have LGBT specific services Breaking free – online Skype/telephone

Work in Clinics and Sauna’s People present much earlier than they would to a drug service Treatment of STIs PeP or PReP Perfect opportunity to deliver motivational & preventative interventions Chemsex Study: preference for clinic based interventions Caution! Approach works well for gay/bi men, may need to think differently for lesbian/bi women & trans people who experience different sexual health barriers

Key Messages Increase own confidence & competence of community/MSM/LGBT issues and newer drugs Be conscious of environment, language, attitude etc. Non-judgmental harm reduction advice Know where & when to refer Be aware of potential G dependence – must see a specialist service for detox advice Safer injecting – needle exchange HIV, Hep, HPV and other STI advice Monitor sexual orientation & gender identity

ANY QUESTIONS ??

RESOURCES • London Friend: http://londonfriend.org.uk/ Antidote: http://londonfriend.org.uk/antidote Out Of Your Mind report: http://londonfriend.org.uk/outofyourmind/ Antidote/Orange Nation G-Aware campaign: http://londonfriend.org.uk/get-support/g-aware/ London Friend CEO Blog : http://londonfriend.org.uk/montys-thoughts/ Chemsex Study: www.sigmaresearch.org.uk/chemsex NTA Club Drug Report: http://www.nta.nhs.uk/uploads/clubdrugsreport2012[0].pdf UK Drug Policy Commission Report: http://www.ukdpc.org.uk/publication/the-impact-drugs-different-minority- groups-lgbt- groups/ UK Drug Policy Commission Policy Briefing: http://www.ukdpc.org.uk/publication/drugs-diversity-lgbt-groups- policy- briefing/ Lesbian & Gay Foundation Part of the Picture: http://www.lgbt.foundation/potp Lancet article of crystal meth rise in London (Jan 2013): http://www.thelancet.com/journals/lancet/article/PIIS0140- 6736(13)60032-X/fulltext CNWL Club Drug Clinic: http://clubdrugclinic.cnwl.nhs.uk/ LDAN News Nov/Dec 2012 (Club Drugs & Antidote articles): http://www.ldan.org.uk/PDFs/LDANNewsDec12.pdf Engendered Penalties: http://www.pfc.org.uk/pdf/EngenderedPenalties.pdf Sexual Orientation Monitoring Guide: http://www.lgbt.foundation/som Stonewall Healthy Lives mini-site: http://www.healthylives.stonewall.org.uk/ Public Health Outcomes Framework LGBT Companion: http://www.lgbt.foundation/phof • • •

CONTACT DETAILS: Tadgh.crozier@lifeline.org.uk Tel: 07584 126 904 Louis.driver@lifeline.org.uk Tel: 07595 415 139 WWW.AFTERPARTY.ORG.UK